Do the ARC-HBR criteria improve the identification of future bleeding risk compared to contemporary bleeding risk scores in patients undergoing percutaneous coronary intervention?
The ARC-HBR criteria provide higher sensitivity but lower specificity than contemporary risk scores for predicting bleeding in patients undergoing PCI.
Patients at HBR defined by the ARC-HBR criteria had a higher risk of BARC 3 or 5 bleeding as well as DOCE. The bleeding risk was related to its individual components. The ARC-HBR criteria were more sensitive for identifying patients with future bleedings than other contemporary risk scores at the cost of specificity. ClinicalTrials.gov Identifier: NCT02241291
Ueki et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: